Why Use a Closed-Flush Blood Sampling System?

A critically ill patient may enter the ICU because of organ failure, extreme dehydration, Sepsis, or some other complicated issue. In all of these conditions, a quick response is best for a positive patient outcome. Invasive hemodynamic monitoring allows a healthcare provider to access real-time information about the patient’s cardiac health. Additionally, blood samples are a routine and vital process to assess the patient’s lung function and perfusion. Multiple blood samples per day is not uncommon in the ICU; however, providers may be unaware of the inherent risks of drawing blood.

Each time a blood sample is drawn, the potential for contamination and blood discard is present. The CDC has made recommendations for improving blood sampling, including the use of a pressure monitoring system with a closed-flush (continuous-flush) sampling system. This type of system can help prevent air-borne contaminants from entering the blood stream. In a study comparing bacterial contamination in arterial lines, the results stated: “There was less microbial contamination of intraluminal fluid when BCS [a blood conservation system] was used for arterial catheterization.”1 Another study, measuring hemoglobin and hematocrit counts of critically ill patients having multiple blood samples drawn, indicated that the use of a closed blood sampling system was able to minimize blood count value changes.2

Merit Medical is proud to offer a portfolio of critical care products including invasive hemodynamic monitoring sets. The MeritransDTXPlus® with Safedraw® closed arterial sampling helps minimize the risk of infection and unnecessary exposure with a simple, closed, in-line arterial sampling system. Unlike other pressure monitoring systems, the EasyVent™ closed zero port allows clinicians to maintain a closed system when priming or zeroing the transducer (not opening the system to the ambient environment reduces patient risk and enhances overall safety).

A new critical care catalog and a brochure are available showing Merit’s critical care portfolio.

  1. Oto J, Nakataki E, Hata M, Tsunano Y, Okuda N, Imanaka H, Nishimura M. (2012 Aug). Comparison of bacterial contamination of blood conservation system and stopcock system arterial sampling lines used in critically ill patients. Am J Infect Control, 40(6):530-4. doi: 10.1016/j.ajic.2011.08.006. Epub2011 Nov 3.
  2. Rezende E, Ferez MA, Silva Junior JM, Oliveira AM, Viana RA, Mendes CL, Toledo Dde O, Ribeiro Neto MC, Setoyama TA. (2010 Mar). Closed system for blood sampling and transfusion in critically ill patients. Rev Bras Ter Intensiva,  22(1):5-10.

NextGenRadial programs and products from Merit Medical

In a press release issued last week, Merit Medical announced its Advanced ThinkRadial Program for Interventional Cardiologists (IC’s), with a curriculum focused on complex interventions accessed via the radial artery. The course will be co-proctored by Interventional Cardiologist Dr. Sandeep Nathan (University of Chicago) and special guest of honor, Dr. Ferdinand Kiemeneij (Tergooi Hospital in Blaricum, The Netherlands), the Father of Transradial Intervention. This course is unique because it focuses on moving IC’s with radial experience to the next level of radial interventions. It will include advanced case presentations, hands-on experiences, and a special presentation by Dr. Kiemeneij about left distal transradial access, the Next Generation of the Radial technique.

Merit is very fortunate to have Dr. Nathan and Dr. Kiemeneij co-proctor the upcoming Advanced Course for Interventional Cardiologists, which will be held October 13-14, 2017 at the Merit Medical Education Center in Salt Lake City, Utah. Dr. Kiemeneij will also co-proctor a total of five courses in 2018 at both the Merit Education Centers in Salt Lake City, Utah and in Maastricht, Netherlands.

Fully committed to the radial approach, Merit offers a full portfolio of radial products, from set-up and access to hemostasis, as well as the ThinkRadial Education Program. Dr. Kiemeneij recently tweeted about using the PreludeEASE for left distal transradial access, a next gen radial entry site in the hand. Read more about his statement in the press release or on twitter.

For more information about Merit Medical and the Next Generation of radial products and programs, visit Merit.com/NextGenRadial.

Study Finds Use of Hemostasis Patch Significantly Reduces Risk of Femoral Artery Compromise in Children

closurepadCardiac Interventions News presented in its May/June issue a study at the 2014 scientific sessions of The Society for Cardiovascular Angiography and Interventions (SCAI) entitled, “Femoral Artery Compromise from Cardiac Catheterization in Children–a Multicenter Study by the CCISC (Congenital Cardiovascular Interventional Study Consortium)” by Thomas J. Forbes, MD. The study concluded that the use of a 3 Fr sheath and hemostasis patch significantly reduced the risk of femoral artery compromise. The study found that “…when a ahemostatic patch was used to seal the wound, the risk of femoral compromise was reduced by approximately two-thirds compared with manual pressure alone.”
The Scion Clo-Sur
PLUS P.A.D.™, sold by Merit Medical, is a sterile topical hemostasis pad intended for the local management of bleeding wounds, including vascular procedure sites.
To learn more about the Scion Clo-sur
PLUS P.A.D., please visit the product’s web page, or contact your Merit Medical Sales Representative.

Mark Heninger
Senior Product Manager

 

Merit Medical 2012: A Year of Accomplishments

As the year comes to a close, I am looking back on 2012 and realizing what an amazing year it has been for Merit Medical. Here are a few of our accomplishments in 2012:

Positive Sales Growth
2012 not only marked Merit’s 25th anniversary, but also 25 straight years of positive sales growth. This is impressive considering how much the struggling economy has impacted many medical device companies in our space. We’re very proud of that.

New Products
The company continues to launch new products, which it has done every year since its founding in 1987. In 2012 we introduced the Blue Diamond™ digital inflation device, the BowTie™ guide wire insertion device, the EndoMAXX® fully covered esophageal stent, and the ONE Snare™ endovascular snare system. We also received 510(k) clearance from the FDA to market the Merit Laureate® hydrophilic guide wire in the United States.

New Product Acquisitions, Alliances and Distribution Agreements
In January, we purchased the Ostial PRO® stent positioning system. In February, we signed a distribution agreement for the Clo-Sur PLUS P.A.D.™ antimicrobial pressure applied device. In September, we purchased the Centros® long-term hemodialysis catheter (and added the CentrosFLO® long-term hemodialysis catheter). In November, we purchased the Flex-Neck® peritoneal dialysis catheter and related products. Recently we announced that Merit entered into a Stock Purchase Agreement to acquire Thomas Medical, Inc. from GE Healthcare, adding products that are recognized as “gold standard” by many of the leading cardiac rhythm management (CRM) and electrophysiology (EP) market participants.

New Facilities
By the end of the year Merit will complete the construction of a new 255,000 square-foot, state-of-the-art, finished goods warehouse and manufacturing facility in South Jordan. We also announced a new R&D facility in Pearland, Texas – a 118,000 square-foot, two-story facility. We completed the expansion of our “Vision Facility” in Galway, Ireland for the assembly of custom procedure packs in Europe.

New Employees
We’re doing our part to help the global economy through the creation of jobs. At the end of 2011, Merit employed about 2,400 employees worldwide, at the end of 2012 we employ more than 2,600 talented people who will help us grow in the future.

New Year
2012 was truly a great year for Merit, but 2013 looks even brighter! Each year we look forward to establishing annual priorities that will help us better serve our customers and further our mission and goals. I’m optimistic about what the New Year holds for our company and for our customers!

Larry Tolman, Vice President, Business Analytics